Erick Lansigan
@thebloodmd.bsky.social
Dartmouth Cancer Center, Hematologist, Lymphoma, Leukemia, Clinical Trials, Fellowship Program Director, Healthy Lifestyles. Social Justice, Health Equity, Global Health. Act Locally, Think Globally.
I’m riding 150 miles to support the Dartmouth Cancer Center! Day 1 tomorrow! Please support me in my emotional return to cycling! getinvolved.dartmouth-hitchcock.org/site/TR/Frie...
The Prouty 2025
Prouty
getinvolved.dartmouth-hitchcock.org
July 11, 2025 at 1:33 AM
I’m riding 150 miles to support the Dartmouth Cancer Center! Day 1 tomorrow! Please support me in my emotional return to cycling! getinvolved.dartmouth-hitchcock.org/site/TR/Frie...
Reposted by Erick Lansigan
If you joined @bsky.app during @ash-hematology.bsky.social #ASH24 here’s a starter pack for transplant, cell & gene therapy #bmtsm #CARTcells #generherapy go.bsky.app/7xxh8WW
December 10, 2024 at 5:35 PM
If you joined @bsky.app during @ash-hematology.bsky.social #ASH24 here’s a starter pack for transplant, cell & gene therapy #bmtsm #CARTcells #generherapy go.bsky.app/7xxh8WW
Reposted by Erick Lansigan
Dr. Jessica Stempel shares results from the phase 2 BLAST trial in acute myeloid leukemia #AML showing that the addition of pembro to azacitidine plus venetoclax was associated with worse outcomes #ASH24.
ash.confex.com/ash/2024/web...
@yale-hematology.bsky.social
ash.confex.com/ash/2024/web...
@yale-hematology.bsky.social
December 10, 2024 at 7:46 PM
Dr. Jessica Stempel shares results from the phase 2 BLAST trial in acute myeloid leukemia #AML showing that the addition of pembro to azacitidine plus venetoclax was associated with worse outcomes #ASH24.
ash.confex.com/ash/2024/web...
@yale-hematology.bsky.social
ash.confex.com/ash/2024/web...
@yale-hematology.bsky.social
Reposted by Erick Lansigan
Navtemadlin Reduces Spleen Size and Symptom Score in R/R Myelofibrosis @ash-hematology.bsky.social #ASH24 #mpnsm #oncology www.onclive.com/view/navtema...
Navtemadlin Reduces Spleen Size and Symptom Score in R/R Myelofibrosis
Navtemadlin monotherapy was safe and effective among patients with myelofibrosis who were relapsed or refractory to treatment with JAK inhibitors.
www.onclive.com
December 10, 2024 at 8:19 PM
Navtemadlin Reduces Spleen Size and Symptom Score in R/R Myelofibrosis @ash-hematology.bsky.social #ASH24 #mpnsm #oncology www.onclive.com/view/navtema...
Reposted by Erick Lansigan
Autologous HCT Does Not Provide Added Survival Benefit in Patients With MCL in First CR @ash-hematology.bsky.social #ASH24 #lymphoma #oncology www.onclive.com/view/autolog...
Autologous HCT Does Not Provide Added Survival Benefit in Patients With MCL in First CR
Results of the EA4151/BMT-CTN 1601 trial showed similar progression-free and overall outcomes with the addition of autologous transplant to rituximab in mantle cell lymphoma.
www.onclive.com
December 10, 2024 at 10:17 PM
Autologous HCT Does Not Provide Added Survival Benefit in Patients With MCL in First CR @ash-hematology.bsky.social #ASH24 #lymphoma #oncology www.onclive.com/view/autolog...
December 10, 2024 at 11:32 AM
Handful of Monday abstracts Dartmouth Cancer Center has worked on at #ASH24 spanning mastocytosis, CLL and hemolytic anemia. Thank you to our patients, collaborators, and pharma partners at in advancing cancer care and gaining new knowledge.
December 10, 2024 at 12:20 AM
Handful of Monday abstracts Dartmouth Cancer Center has worked on at #ASH24 spanning mastocytosis, CLL and hemolytic anemia. Thank you to our patients, collaborators, and pharma partners at in advancing cancer care and gaining new knowledge.
Amazing talk in the #ASH24 Health Equity Studio today by @kekoamdphd.bsky.social. Wonderful to see and started the day off brightly!
December 9, 2024 at 6:05 PM
Amazing talk in the #ASH24 Health Equity Studio today by @kekoamdphd.bsky.social. Wonderful to see and started the day off brightly!
One idea for creating an environment of #inclusion is to provide interpreters for the speakers whom English is not their native language especially during question and answers. #ash24
December 8, 2024 at 2:18 AM
One idea for creating an environment of #inclusion is to provide interpreters for the speakers whom English is not their native language especially during question and answers. #ash24
Well done study! “Impact of Minimal Residual Disease Analysis in the Era of Rituximab Maintenance in Follicular Lymphoma: Data from 'FOLL12' Phase III Trial of the Fondazione Italiana Linfoma”
Congrats to Simone Ferrero and the group.
My favorite abstract of the day! #ash24
Congrats to Simone Ferrero and the group.
My favorite abstract of the day! #ash24
December 8, 2024 at 12:52 AM
Well done study! “Impact of Minimal Residual Disease Analysis in the Era of Rituximab Maintenance in Follicular Lymphoma: Data from 'FOLL12' Phase III Trial of the Fondazione Italiana Linfoma”
Congrats to Simone Ferrero and the group.
My favorite abstract of the day! #ash24
Congrats to Simone Ferrero and the group.
My favorite abstract of the day! #ash24
Kicked off #ASH24 with a bike ride, coffee, and ferry out to Coronado Island with some great friends. I vote San Diego as the best place for ASH.
December 7, 2024 at 12:46 PM
Kicked off #ASH24 with a bike ride, coffee, and ferry out to Coronado Island with some great friends. I vote San Diego as the best place for ASH.
Has anyone written about migrating #MedTwitter over to #Medsky? Good article on #bluesky. www.nytimes.com/2024/12/07/o...
Opinion | Bluesky Is Different From X. For Now.
Users are looking for a more curated experience on a platform that is not constantly trying to get them to interact with brands.
www.nytimes.com
December 7, 2024 at 12:37 PM
Has anyone written about migrating #MedTwitter over to #Medsky? Good article on #bluesky. www.nytimes.com/2024/12/07/o...
My #ASHThrowback is from 1997 in San Diego when I was a lab tech with @roberta_kato in Dr . David Rawlings lab where we were studying gene therapy for BTK in XLA. Now we are trying to inhibit and degrade #BTK and #genetherapy finally made it in lymphoma #CART and sickle. I was hooked then and now.
December 5, 2024 at 6:55 PM
My #ASHThrowback is from 1997 in San Diego when I was a lab tech with @roberta_kato in Dr . David Rawlings lab where we were studying gene therapy for BTK in XLA. Now we are trying to inhibit and degrade #BTK and #genetherapy finally made it in lymphoma #CART and sickle. I was hooked then and now.
I wonder how people are using X and able to filter out the noise? The energy definitely shifted when it became X. When I joined Twitter I had one account for everything. #MedSky sounds much better then MedTwitter or MedX. The Sky represents hope and expansiveness, while X signifies elimination.
December 5, 2024 at 12:44 PM
I wonder how people are using X and able to filter out the noise? The energy definitely shifted when it became X. When I joined Twitter I had one account for everything. #MedSky sounds much better then MedTwitter or MedX. The Sky represents hope and expansiveness, while X signifies elimination.
Hello #ASH24! Can ASH help create starter packs of anyone who posts on hashtag #ASH24 on a daily basis? @ash-hematology.bsky.social
December 5, 2024 at 12:27 PM
Hello #ASH24! Can ASH help create starter packs of anyone who posts on hashtag #ASH24 on a daily basis? @ash-hematology.bsky.social
@thebloodmd.bsky.social is looking forward to #ash24 #medsky #hemesky #oncsky and growing a new platform. Who will be my first follower? 😊
December 5, 2024 at 7:24 AM
@thebloodmd.bsky.social is looking forward to #ash24 #medsky #hemesky #oncsky and growing a new platform. Who will be my first follower? 😊